GNH USA

USA — NDC

Pristiq Extended-Release 100 mg/1

Pristiq Extended-Release 100 mg/1 is an antidepressant medication used to manage major depressive disorder. This extended-release tablet contains desvenlafaxine

Desvenlafaxine Succinate
Pristiq Extended-Release
TABLET, EXTENDED RELEASE
100 mg/1

Request sourcing

1
Pack/s

What is Desvenlafaxine Succinate?

Pristiq Extended-Release 100 mg/1 is an antidepressant medication used to manage major depressive disorder. This extended-release tablet contains desvenlafaxine succinate, offering a convenient once-daily option for consistent symptom relief. Learn more about its uses, effects, and precautions.

What is Desvenlafaxine Succinate used for?

Pristiq Extended-Release 100 mg/1 is primarily used to treat major depressive disorder (MDD). Desvenlafaxine succinate, the active ingredient, works to restore the balance of certain natural substances in the brain. This medication is often prescribed for individuals seeking relief from persistent feelings of sadness, hopelessness, or other symptoms associated with depression. What is Pristiq used for? It is designed to help manage emotional and physical symptoms of depression, promoting overall well-being.

What are the side effects of Desvenlafaxine Succinate?

Common effects of Pristiq Extended-Release 100 mg/1 may include nausea, dizziness, and fatigue. Some users may experience dry mouth, insomnia, or constipation. These effects can vary in intensity and duration, depending on individual responses. It is important to monitor how your body reacts to this medication and consult a healthcare provider if any effects become severe or persistent.

What precautions apply to Desvenlafaxine Succinate?

Pristiq Extended-Release 100 mg/1 should be handled with care. Store the medication in a cool, dry place away from direct sunlight and out of reach of children. Do not crush, chew, or break the extended-release tablets, as this can alter their effectiveness. Always follow the prescribed dosage and administration instructions provided by your healthcare provider.

What does Desvenlafaxine Succinate interact with?

Pristiq Extended-Release 100 mg/1 may interact with other medications, including those that affect serotonin levels. Alcohol should be avoided while taking this medication, as it can increase the risk of side effects. Certain CYP inhibitors, such as fluoxetine or paroxetine, may also interact with desvenlafaxine succinate. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently asked questions

What is Pristiq Extended-Release 100 mg/1 used for?+
Pristiq Extended-Release 100 mg/1 is used to treat major depressive disorder (MDD). It helps manage symptoms such as persistent sadness, hopelessness, and other emotional and physical effects of depression.
How should I take Pristiq Extended-Release 100 mg/1?+
Pristiq Extended-Release 100 mg/1 should be taken orally, typically once daily. The tablets should be swallowed whole with water, and should not be crushed, chewed, or broken.
What are the common side effects of Pristiq Extended-Release 100 mg/1?+
Common side effects may include nausea, dizziness, fatigue, dry mouth, insomnia, and constipation. These effects can vary in intensity and duration.
Can I drink alcohol while taking Pristiq Extended-Release 100 mg/1?+
It is generally advised to avoid alcohol while taking Pristiq Extended-Release 100 mg/1, as it can increase the risk of side effects.
What should I do if I miss a dose of Pristiq Extended-Release 100 mg/1?+
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose to catch up.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Desvenlafaxine Succinate
Brand
Pristiq Extended-Release
Strength
100 mg/1
Form
TABLET, EXTENDED RELEASE
Route
ORAL
Pack size
14 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-14)
Manufacturer
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Origin
USA

Related products